2020
DOI: 10.1136/ijgc-2019-001176
|View full text |Cite
|
Sign up to set email alerts
|

British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)

Abstract: The National Cancer Survivorship Initiative through the National Health Service (NHS) improvement in the UK started the implementation of stratified pathways of patient-initiated follow-up (PIFU) across various tumor types. Now the initiative is continued through the Living With and Beyond Cancer program by NHS England. Evidence from non-randomized studies and systematic reviews does not demonstrate a survival advantage to the long-established practice of hospital-based follow-up regimens, traditionally over 5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
33
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(34 citation statements)
references
References 36 publications
(38 reference statements)
1
33
0
Order By: Relevance
“…Before the pandemic, follow-up guidelines and recommendations were published for the management of gynecologic cancer survivors. [17][18][19][20][21][22] The COVID-19 crisis may encourage implementation of less intensive and more cost-effective surveillance, and it may be an opportunity for integrating telemedicine and shared decisionmaking processes into the healthcare system. These changes may permanently transform the follow-up of gynecologic cancer survivors and offer a personalized approach.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Before the pandemic, follow-up guidelines and recommendations were published for the management of gynecologic cancer survivors. [17][18][19][20][21][22] The COVID-19 crisis may encourage implementation of less intensive and more cost-effective surveillance, and it may be an opportunity for integrating telemedicine and shared decisionmaking processes into the healthcare system. These changes may permanently transform the follow-up of gynecologic cancer survivors and offer a personalized approach.…”
Section: Discussionmentioning
confidence: 99%
“…A review of the evidence-based data and established guidelines was performed to identify signs of recurrence and abandon unnecessary or wasteful interventions. [17][18][19][20][21][22][23][24] As a consequence, we propose telemedicine-based, risk-stratified surveillance schemes supported by evidence and a shared decision-making program for gynecologic cancer survivors in the COVID-19 era.…”
Section: Introductionmentioning
confidence: 99%
“…31 36 Oncological treatment guidelines Many of the recommendations listed above relating to surgical procedures also apply to oncological treatments. Outpatient follow-up has been changed in many hospitals to telephone and video consultations or patient initiated follow-up 37 ; non-essential follow-up has been stopped, and other procedures such as blood tests are done locally or using a drive-through service. 9 Oral medication is delivered home and hospital visits are minimized.…”
Section: Patient Perspectives European Society Of Gynecological Oncolmentioning
confidence: 99%
“…This is also the case internationally ( Kew and Cruickshank, 2006 ). The aim of this practice is to detect asymptomatic recurrences and, through earlier detection, improve outcome, as well as manage side effects of treatment and provide support ( Newton et al, 2020 ). Evidence demonstrating improved survival for this practice is lacking ( Owen and Duncan, 1996 , Fung-Kee-Fung et al, 2006 ) and evidence also suggests that this regime may not meet cancer survivors needs ( Sperling et al, 2014 ).…”
Section: Introductionmentioning
confidence: 99%